Encouraging results from novel cancer treatments, as presented at ASCO, are offering new hope for cancer patients and deepening the potential of precision medicine. MedCity’s CONVERGE conference in Philadelphia June 19 will highlight how innovation in cancer treatment is supported in areas such as health tech, value-based care, population health and the patient experience.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Register now to be part of the conversation.
The conference, which will be held at the University City Science Center, brings together all sectors of the oncology ecosystem—health systems, insurers, digital health, investors, hospitals, pharma, entrepreneurs and other key stakeholders—to discover the latest innovations and the future of cancer care.
Through a mix of provocative conversations, interactive networking, and a showcase of the hottest startups, you’ll get actionable insight into how AI, big data, precision medicine and more are transforming cancer treatment.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Among the highlights of the agenda are a panel that will illustrate how connected health can improve the patient experience with participants including:
- Roy Rosin, Chief Innovation Officer, Penn Medicine, University of Pennsylvania Health System;
- Michael Vennera, SVP, Chief Information Officer, Independence Blue Cross;
- Rakesh Mathew, Chief Innovation Officer & Senior Director of Technology, HealthShare Exchange
- Dr. Bhagirathbhai Dholaria, Assistant Professor, Department of Hematology-Oncology, Vanderbilt University Medical Center;
- Deepti Jaggi, President and CMO, Clinakos
Artificial intelligence has captured the healthcare industry’s attention as a way not only to identify targets for drug development but also to spot patterns that lead up to adverse events to spur earlier intervention and tools to improve clinical decision support. But the challenge of using unstructured data to scale AI applications is also significant and will be the focus of a panel discussion including:
- Christopher Boone, Vice President, Head of Real World Data & Analytics, Pfizer;
- Dr. Nate Nussbaum, Senior Medical Director, Flatiron Health;
- Dr. Gaurav Singal, Chief Data Officer, Foundation Medicine;
- Janak Joshi, SVP, Chief Technology Officer and Head of Strategy, Life Image
Startups always play a critical role at MedCity’s conferences and CONVERGE is no different. We will have up to 10 healthcare businesses addressing cancer treatment and precision medicine such as:
- Respiratory drug delivery business Quench Medical;
- A search engine for identifying personalized cancer treatment SEngine Precision Medicine;
- Digital medicine platform Rx.Health;
- RNA profiling company Cofactor Genomics;
- Using machine learning to spot risk factors for patients to be diagnosed with specific medical conditions Medial EarlySign.
Photo: Natali_Mis, Getty Images
